Agente para su uso en el caso de intolerancia a la fructosa
Glucosa isomerasa para su uso por administración oral en la terapia de intolerancia intestinal a la fructosa, siempre que la glucosa isomerasa no se use en combinación con 5-D-fructosa deshidrogenasa para dicha terapia. An agent is described that, with the help of glucose isomerase, converts fructos...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Spanish |
Published |
21.09.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Glucosa isomerasa para su uso por administración oral en la terapia de intolerancia intestinal a la fructosa, siempre que la glucosa isomerasa no se use en combinación con 5-D-fructosa deshidrogenasa para dicha terapia.
An agent is described that, with the help of glucose isomerase, converts fructose into glucose and thus, alone or in combination with 5-D-fructose dehydrogenase, reduces the bioavailability of fructose in the human or animal body. This agent can be used in particular in the therapy of fructose intolerance. |
---|---|
AbstractList | Glucosa isomerasa para su uso por administración oral en la terapia de intolerancia intestinal a la fructosa, siempre que la glucosa isomerasa no se use en combinación con 5-D-fructosa deshidrogenasa para dicha terapia.
An agent is described that, with the help of glucose isomerase, converts fructose into glucose and thus, alone or in combination with 5-D-fructose dehydrogenase, reduces the bioavailability of fructose in the human or animal body. This agent can be used in particular in the therapy of fructose intolerance. |
Author | WYROBNIK, Isaac WYROBNIK, Daniel |
Author_xml | – fullname: WYROBNIK, Daniel – fullname: WYROBNIK, Isaac |
BookMark | eNqNyjsOwjAQRVEXUPDbw7AAGlyQKBVCQfS4j0bmBUWyZiyPvX8oWADVPcXdupWoYOOG6xtSQZkLkzVqpgQhJIr85Qu0SNWEwhIXJqbENJcWqxrv3XrmZDj8unPH-xhujxOyTrDMEYI6jc_zpfN914fg_T_PB0KoMLY |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | ES2783989TT3 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_ES2783989TT33 |
IEDL.DBID | EVB |
IngestDate | Fri Oct 18 06:06:31 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Spanish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_ES2783989TT33 |
Notes | Application Number: ES20180188695T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200921&DB=EPODOC&CC=ES&NR=2783989T3 |
ParticipantIDs | epo_espacenet_ES2783989TT3 |
PublicationCentury | 2000 |
PublicationDate | 20200921 |
PublicationDateYYYYMMDD | 2020-09-21 |
PublicationDate_xml | – month: 09 year: 2020 text: 20200921 day: 21 |
PublicationDecade | 2020 |
PublicationYear | 2020 |
RelatedCompanies | Vitacare GmbH & Co. KG |
RelatedCompanies_xml | – name: Vitacare GmbH & Co. KG |
Score | 3.1432097 |
Snippet | Glucosa isomerasa para su uso por administración oral en la terapia de intolerancia intestinal a la fructosa, siempre que la glucosa isomerasa no se use en... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES |
Title | Agente para su uso en el caso de intolerancia a la fructosa |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200921&DB=EPODOC&locale=&CC=ES&NR=2783989T3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6LzgwjSt2I_tjVFirh-MAS3oVX2NtImQqG0w7b473sJrfqib0cSwiVwubvc3e8Abrgjwzvc0F3XSvUR5Ux3Dcp0yl10xizboYlC-5xPZq-jx9V41YOsq4VROKGfChwRJSpFea_Ve735-cQKVG5ldZtkOFTeR7EXaK13rCCETC2YeuFyESx8zfc9NKrmz55sKOFSN7a3YButaEdmf4VvU1mUsvmtUaID2FniZkV9CD1RDWDP7xqvDWD3qY13I9mKXnUEdw-yCEoQidVNqoY0VUlEQUROUoYkFyQr6jIXqlEGI4zkjLxLbNiyYsdwHYWxP9ORi_X3idfhS8dvbNsn0C_KQpwCMYRNKTdFOhFoxeACtI1ogjpGjHmSmvwMhn_vM_xv8hz25e3JRAjLvIB-_dGIS9S2dXKl7ukL5nGDNg |
link.rule.ids | 230,309,783,888,25578,76886 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3rS8MwED_mFOc3ncqcrwiyb8U-9kiRIq4Ppu6FVtm3kjYRCqMdtsV_30vY1C_6LSQhXA5-uUty9zuAaz6Q3ztc12zbTLQu5Uyzdco0ym28jJnWgMaK7XPaH712Hxe9RQ3STS6M4gn9VOSIiKgE8V6q83r184jlqdjK4iZOsSu_C0LH66xvx4pCyOh4Q8efz7yZ23FdB52q6bMjC0rY1A6tLdhG4agEg_82lEkpq98WJdiHnTkulpUHUBNFExrupvBaE3Yn6_9ubK6hVxzC7b1MghJEcnWToiJVkROREbEkCcMmFyTNynwpVKEMRhhZMvIuuWHzgh3BVeCH7khDKaLvHUf-y0be0LKOoZ7lmWgB0YVFKTdE0hfoxeAE9I1ojDZG9HicGPwE2n-v0_5v8BIao3AyjsYP06dT2JOalEERpnEG9fKjEudoecv4QunsCzgehig |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Agente+para+su+uso+en+el+caso+de+intolerancia+a+la+fructosa&rft.inventor=WYROBNIK%2C+Daniel&rft.inventor=WYROBNIK%2C+Isaac&rft.date=2020-09-21&rft.externalDBID=T3&rft.externalDocID=ES2783989TT3 |